Current Issue: September 2020
Multicenter randomized trial of endoscopic papillary large balloon dilation without sphincterotomy versus endoscopic sphincterotomy for removal of bile duct stones: MARVELOUS trial
by Hirofumi Kogure, Shuhei Kawahata, Tsuyoshi Mukai et al.
The efficacy and safety of endoscopic papillary large balloon dilation (EPLBD) alone versus endoscopic sphincterotomy (EST) were compared for the removal of large (≥ 10mm)common bile duct stones. EPLBD without EST resulted in a higher single-session complete stone removal rate compared with EST (91% vs. 79%), without increasing adverse events.
22G Acquire vs. 20G Procore needle for endoscopic ultrasound-guided biopsy of pancreatic masses: a randomized study comparing histologic sample quantity and diagnostic accuracy
by David Karsenti, Laurent Palazzo, Bastien Perrot et al.
Crossover trial comparing two new endoscopic ultrasound fine-needle biopsy needles in 60 patients with pancreatic masses. It was concluded that a single pass with the 22G Acquire needle provided more tissue for histologic evaluation and a better diagnostic accuracy than a single pass with the 20G Procore needle.
Read more here.
Sorry no content available
Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement - Update 2020
by Gregorios A. Paspatis, Marianna Arvanitakis, Jean-Marc Dumonceau et al.
Iatrogenic perforations during GI endoscopy are rare but severe adverse events with high risk of morbidity and mortality; therefore adequate diagnosis and management are of paramount importance. This updated 2020 ESGE Position Statement reviews the definition, diagnosis, risk factors, and management of inadvertent iatrogenic perforation occurring during GI endoscopy. It also presents easy-to-follow algorithms for the management of ERCP-related iatrogenic perforations according to Stapfer type and for the management of colonic iatrogenic perforations.